Alison Yi-Jou Huang, Ph.D., is a regulatory affairs professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as a Manager in Regulatory Affairs at Bristol Myers Squibb since January 2024, Alison previously held managerial roles at Mirati Therapeutics and contributed to various aspects of regulatory submissions for oncology drugs. Prior experience includes regulatory medical writing at CRC Oncology and in vivo pharmacology at WuXi AppTec. Notable academic background includes a Ph.D. in Biology from UC San Diego, along with certifications in Clinical Research Conduct and Management as well as Regulatory Affairs & Compliance.